Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2014 (2014), Article ID 976321, 12 pages
http://dx.doi.org/10.1155/2014/976321
Review Article

Autologous Cord Blood Therapy for Infantile Cerebral Palsy: From Bench to Bedside

Campus Clinic Gynecology, Ruhr-University Bochum, Universitätsstraße 140, 44799 Bochum, Germany

Received 26 September 2013; Accepted 28 December 2013; Published 20 February 2014

Academic Editor: Brian J. Koos

Copyright © 2014 A. Jensen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Kancherla, D. D. Amendah, S. D. Grosse, M. Yeargin-Allsopp, and K. van Naarden Braun, “Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children,” Research in Developmental Disabilities, vol. 33, no. 3, pp. 832–840, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Novak, M. Hines, S. Goldsmith, and R. Barclay, “Clinical prognostic messages from a systematic review on cerebral palsy,” Pediatrics, vol. 130, no. 5, pp. e1285–e1312, 2012. View at Publisher · View at Google Scholar
  3. A. Struck, M. Almaazmi, H. Bode et al., “Neurodevelopmental outcome of very low birth weight infants born at the Perinatal Centre in Ulm, Germany,” Zeitschrift für Geburtshilfe und Neonatologie, vol. 217, no. 2, pp. 65–71, 2013. View at Publisher · View at Google Scholar
  4. M. Irazábal, F. Marsà, M. García et al., “Family burden related to clinical and functional variables of people with intellectual disability with and without a mental disorder,” Research in Developmental Disabilities, vol. 33, no. 3, pp. 796–803, 2012. View at Publisher · View at Google Scholar
  5. Centers for Disease Control and Prevention (CDC), “Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment—United States,” Morbidity and Mortality Weekly Report, vol. 53, pp. 57–59, 2003. View at Google Scholar
  6. C. de Duve, T. de Barsy, B. Poole, A. Trouet, P. Tulkens, and F. van Hoof, “Commentary. Lysosomotropic agents,” Biochemical Pharmacology, vol. 23, no. 18, pp. 2495–2531, 1974. View at Publisher · View at Google Scholar · View at Scopus
  7. D. T. Harris, “Non-haematological uses of cord blood stem cells,” The British Journal of Haematology, vol. 147, no. 2, pp. 177–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Kurtzberg, “Update on umbilical cord blood transplantation,” Current Opinion in Pediatrics, vol. 21, no. 1, pp. 22–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Rosenkranz and C. Meier, “Umbilical cord blood cell transplantation after brain ischemia—from recovery of function to cellular mechanisms,” Annals of Anatomy, vol. 193, no. 4, pp. 371–379, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Carroll, “Human cord blood for the hypoxic-ischemic neonate,” Pediatric Research, vol. 71, no. 4, part 2, pp. 459–463, 2012. View at Publisher · View at Google Scholar
  11. K. Min, J. Song, J. Y. Kang et al., “Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial,” Stem Cells, vol. 31, no. 3, pp. 581–591, 2013. View at Publisher · View at Google Scholar
  12. J. M. M. Gijtenbeek, M. J. van den Bent, and C. J. Vecht, “Cyclosporine neurotoxicity: a review,” Journal of Neurology, vol. 246, no. 5, pp. 339–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Garnier, H. M. Vaihinger, J. Middelanis, O. Brüstle, and A. Jensen, “Cerebral ischemia and umbilical stem cell transplantation in chronically prepared fetal sheep,” in Proceedings of the 1st International Meeting of the Stem Cell Network, p. 10, North Rhine-Westphalia, Germany, 2002.
  14. J. Middelanis, H. M. Vaihinger, Y. Garnier, K. Gottmann, H. Dinse, and A. Jensen, “A model of neonatal cerebral ischemia in rats (“levine”) to study neuroprotection and neuroregeneration,” in Proceedings of the 1st International Meeting of the Stem Cell Network, p. 11, North Rhine-Westphalia, Germany, 2002.
  15. A. Jensen, H. Vaihinger, and C. Meier, “Perinatal brain damage—from neuroprotection to neuroregeneration using cord blood stem cells,” Medizinische Klinik, vol. 98, no. 2, pp. 22–26, 2003. View at Google Scholar · View at Scopus
  16. B. Clancy, B. L. Finlay, R. B. Darlington, and K. J. S. Anand, “Extrapolating brain development from experimental species to humans,” NeuroToxicology, vol. 28, no. 5, pp. 931–937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Meier, J. Middelanis, B. Wasielewski et al., “Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells,” Pediatric Research, vol. 59, no. 2, pp. 244–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Castillo-Melendez, T. Yawno, G. Jenkin, and S. L. Miller, “Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells,” Frontiers in Neuroscience, vol. 7, article 194, pp. 1–14, 2013. View at Google Scholar
  19. O. Dammann and A. Leviton, “Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant,” Seminars in Pediatric Neurology, vol. 5, no. 3, pp. 190–201, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Fujita, M. Ihara, T. Ushiki et al., “Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow,” Stroke, vol. 41, no. 12, pp. 2938–2943, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Cao, J. H. Wang, Z. J. Dai et al., “Topological organization of the human brain functional connectome across the lifespan,” Developmental Cognitive Neuroscience, vol. 7, pp. 76–93, 2014. View at Publisher · View at Google Scholar
  22. S. Neuhoff, J. Moers, M. Rieks et al., “Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro,” Experimental Hematology, vol. 35, no. 7, pp. 1119–1131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Chen, P. R. Sanberg, Y. Li et al., “Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats,” Stroke, vol. 32, no. 11, pp. 2682–2688, 2001. View at Google Scholar · View at Scopus
  24. H. Y. Liu, Q. J. Zhang, H. J. Li, and Z. C. Han, “Effect of intracranial transplantation of CD34+ cells derived from human umbilical cord blood in rats with cerebral ischemia,” Chinese Medical Journal, vol. 119, no. 20, pp. 1744–1748, 2006. View at Google Scholar · View at Scopus
  25. B. Wasielewski, A. Jensen, A. Roth-Härer, R. Dermietzel, and C. Meier, “Neuroglial activation and Cx43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury,” Brain Research, vol. 1487, pp. 39–53, 2012. View at Publisher · View at Google Scholar
  26. K. Rosenkranz, S. Kumbruch, K. Lebermann et al., “The chemokine SDF-1/CXCL12 contributes to the “homing” of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain,” Journal of Neuroscience Research, vol. 88, no. 6, pp. 1223–1233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Jiang, M. Newman, S. Saporta et al., “MIP-1α and MCP-1 induce migration of human umbilical cord blood cells in models of stroke,” Current Neurovascular Research, vol. 5, no. 2, pp. 118–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Geißler, H. R. Dinse, S. Neuhoff, K. Kreikemeier, and C. Meier, “Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex,” PLoS ONE, vol. 6, no. 6, Article ID e20194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. J. Neafsey, E. L. Bold, G. Haas et al., “The organization of the rat motor cortex: a microstimulation mapping study,” Brain Research, vol. 396, no. 1, pp. 77–96, 1986. View at Google Scholar · View at Scopus
  30. A. Horvat, F.-W. Schwaiger, G. Hager et al., “A novel role for protein tyrosine phosphatase SHP1 in controlling glial activation in the normal and injured nervous system,” Journal of Neuroscience, vol. 21, no. 3, pp. 865–874, 2001. View at Google Scholar · View at Scopus
  31. C. A. Beamer, D. M. Brooks, and D. I. Lurie, “Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia,” Journal of Neuroscience Research, vol. 83, no. 7, pp. 1220–1230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Burtrum and F. S. Silverstein, “Hypoxic-ischemic brain injury stimulates glial fibrillary acidic protein mRNA and protein expression in neonatal rats,” Experimental Neurology, vol. 126, no. 1, pp. 112–118, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Wishcamper, D. M. Brooks, J. D. Coffin, and D. I. Lurie, “Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice,” Brain Research, vol. 974, no. 1-2, pp. 88–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Nakase, Y. Yoshida, and K. Nagata, “Enhanced connexin 43 immunoreactivity in penumbral areas in the human brain following ischemia,” GLIA, vol. 54, no. 5, pp. 369–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Shaked, Z. Porat, R. Gersner, J. Kipnis, and M. Schwartz, “Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system,” Journal of Neuroimmunology, vol. 146, no. 1-2, pp. 84–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. A. D. Bachstetter, M. M. Pabon, M. J. Cole et al., “Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain,” BMC Neuroscience, vol. 9, article 22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Rosenkranz, S. Kumbruch, M. Tenbusch et al., “Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats,” Cell and Tissue Research, vol. 348, no. 3, pp. 429–438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. B. H. Han and D. M. Holtzman, “BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway,” Journal of Neuroscience, vol. 20, no. 15, pp. 5775–5781, 2000. View at Google Scholar · View at Scopus
  39. K. Jin, Y. Zhu, Y. Sun, X. O. Mao, L. Xie, and D. A. Greenberg, “Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11946–11950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Muramatsu, A. Fukuda, H. Togari, Y. Wada, and H. Nishino, “Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier,” Stroke, vol. 28, no. 11, pp. 2281–2289, 1997. View at Google Scholar · View at Scopus
  41. S. Fukuhara, K. Sako, T. Minami et al., “Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1,” Nature Cell Biology, vol. 10, no. 5, pp. 513–526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. K. I. Papadopoulos, S. S. S. Low, T. C. Aw, and T. Chantarojanasiri, “Safety and feasibility of autologous umbilical cord blood transfusion in 2 toddlers with cerebral palsy and the role of low dose granulocyte-colony stimulating factor injections,” Restorative Neurology and Neuroscience, vol. 29, no. 1, pp. 17–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Jensen, “First therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest? Individual treatment by transplantation of autologous cord blood stem cells,” Regenerative Medizin, vol. 4, no. 1, pp. 30–31, 2011. View at Google Scholar
  44. A. Jensen and E. Hamelmann, “First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest—individual treatment with cord blood,” Case Reports in Transplantation, vol. 2013, Article ID 951827, 6 pages, 2013. View at Publisher · View at Google Scholar
  45. Y.-H. Lee, K. V. Choi, J. H. Moon et al., “Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy,” Journal of Translational Medicine, vol. 10, article 58, pp. 1–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Sun, J. Allison, C. McLaughlin et al., “Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders,” Transfusion, vol. 50, no. 9, pp. 1980–1987, 2010. View at Publisher · View at Google Scholar · View at Scopus